Transfusion-transmitted infectious diseases

Petersen, 2004, Westward ho? – the spread of West Nile virus, N Engl J Med, 351, 2257, 10.1056/NEJMp048261 Lealer, 2003, Transmission of West Nile virus through blood transfusion in the United States in 2002, N Engl J Med, 349, 1236, 10.1056/NEJMoa030969 Stramer, 2005, West Nile virus among blood donors in the United States, 2003 and 2004, N Engl J Med, 353, 451, 10.1056/NEJMoa044333 Bianco C. Dengue and Chikungunya viruses in blood donations: risks to the blood supply? [editorial]. Transfusion, 2008;48:1279–81. Charrel, 2007, Chikungunya outbreaks – the globalization of vectorborne diseases, N Engl J Med, 356, 769, 10.1056/NEJMp078013 Mohammed, 2008, Dengue virus in blood donations, Puerto Rico, 2005, Transfusion, 48, 1348, 10.1111/j.1537-2995.2008.01771.x Linnen, 2008, Dengue viremia in blood donors from Honduras, Brazil, and Australia, Transfusion, 48, 1355, 10.1111/j.1537-2995.2008.01772.x Stramer, 2007, US blood donor screening for Trypanosoma cruzi: clinical studies and early assessment of prevalence, Transfusion, 47, 1A Mungai, 2001, Transfusion-transmitted malaria in the United States from 1963 through 1999, N Engl J Med, 344, 1973, 10.1056/NEJM200106283442603 Leiby, 2007, Making sense of malaria, Transfusion, 47, 1573, 10.1111/j.1537-2995.2007.01418.x Seed, 2005, The efficacy of a malarial antibody enzyme immunoassay for establishing the reinstatement status of blood donors potentially exposed to malaria, Vox Sang, 88, 98, 10.1111/j.1423-0410.2005.00605.x Nguyen, 2007, The continuing impact of malaria deferrals on blood donations, Transfusion, 47, 9A Leiby, 2006, Babesiosis and blood transfusion: flying under the radar, Vox Sang, 90, 157, 10.1111/j.1423-0410.2006.00740.x Hewitt, 2006, Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study, Vox Sang, 91, 221, 10.1111/j.1423-0410.2006.00833.x Zou, 2008, Transfusion transmission of human prion diseases, Transfus Med Rev, 22, 58, 10.1016/j.tmrv.2007.09.003 Ironside, 2006, Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study, Br Med J, 332, 1186, 10.1136/bmj.38804.511644.55 Carneiro-Proietti, 2006, The Hemominas foundation of Brazil: quality management in a hybrid model, 155 Proietti, 2005, Global epidemiology of HTLV-1 infection and associated diseases, Oncogene, 24, 6058, 10.1038/sj.onc.1208968 Allain, 2004, Occult hepatitis B virus infection: implications in transfusion, Vox Sang, 86, 83, 10.1111/j.0042-9007.2004.00406.x Allain, 2006, A European perspective on the management of donors and units testing positive for hepatitis B virus DNA, Transfusion, 46, 1256, 10.1111/j.1537-2995.2006.00885.x Biswas, 2003, Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection, Transfusion, 43, 788, 10.1046/j.1537-2995.2003.00424.x Brojer, 2006, Characterization of HBV DNA positive/HBsAg negative blood donors identified in the Polish NAT screening program, Hepatology, 44, 1666, 10.1002/hep.21413 Heyns, 2006, The impact of individual donation NAT screening on blood safety, Vox Sang, 93, 203, 10.1111/j.1751-2824.2006.00030.x Candotti, 2007, Maternofetal transmission of Hepatitis B virus genotype E in Ghana, West Africa, J Gen Virol, 88, 2686, 10.1099/vir.0.83102-0 Rehermann, 1996, The hepatitis B virus persists for decades after patients recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response, Nat Med, 2, 1104, 10.1038/nm1096-1104 Zahn, 2008, Molecular characterization of occult hepatitis B in genotype E-infected subjects, J Gen Virol, 89, 409, 10.1099/vir.0.83347-0 Satake, 2007, Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program, Transfusion, 47, 1197, 10.1111/j.1537-2995.2007.01276.x Gerlich, 2006, Breakthrough of hepatitis B virus escape mutants after vaccination and virus reactivation, J Clin Virol, 36, S18, 10.1016/S1386-6532(06)80004-1 Dickson, 1997, Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation database, Gastroenterology, 113, 1668, 10.1053/gast.1997.v113.pm9352871 Dodson, 1997, Infectivity of hepatic allografts with antibodies to hepatitis B virus, Transplantation, 64, 1582, 10.1097/00007890-199712150-00013 Dodson, 1999, Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors, Transplantation, 68, 1058, 10.1097/00007890-199910150-00028 Prakoso, 2006, Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors, Clin Transplant, 30, 369, 10.1111/j.1399-0012.2006.00495.x Knöll, 2005, Solid-organ transplantation in HBsAg-negative patients with antibodies to HBV core antigen: low risk of HBV reactivation, Transplantation, 79, 1631, 10.1097/01.TP.0000163468.80223.74 Perez, 2006, Is hepatitis C more aggressive in renal transplant patients than in patients with end-stage renal disease?, J Clin Gastroenterol, 40, 444, 10.1097/00004836-200605000-00016 Vallet-Pichard, 2006, Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection, J Hepatol, 44, S28, 10.1016/j.jhep.2005.11.008 Dienstag, 1997, Sexual and perinatal transmission of hepatitis C, Hepatology, 26, 66S, 10.1002/hep.510260712 Ho, 1990, Epidemiology of cytomegalovirus infections, Rev Infect Dis, 12, S701, 10.1093/clinids/12.Supplement_7.S701 Bowden, 1995, A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant, Blood, 86, 3598, 10.1182/blood.V86.9.3598.bloodjournal8693598 Sandherr, 2006, Antiviral prophylaxis in patients with haematological malignancies and solid tumours: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO), Ann Oncol, 17, 1051, 10.1093/annonc/mdj132 Kumar, 2004, A seroprevalence study of West Nile virus infection in solid organ transplant recipients, Am J Transplant, 4, 1883, 10.1111/j.1600-6143.2004.00592.x Iwamoto, 2003, Transmission of West Nile virus from an organ donor to four transplant recipients, N Engl J Med, 348, 2196, 10.1056/NEJMoa022987 Nakamura, 1998, Influence of immunosuppression in HTLV-1-positive renal transplant recipients, Transplant Proc, 30, 1324, 10.1016/S0041-1345(98)00261-9 Casoli, 2007, Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression, AIDS Rev, 9, 140 Musiani, 1995, Persistent B19 parvovirus infections in haemophilic HIV-1 infected patients, J Med Virol, 46, 10.1002/jmv.1890460204